{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:39:13Z","timestamp":1792478353342,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJWJ2022XK022"],"award-info":[{"award-number":["TJWJ2022XK022"]}]},{"name":"Tianjin Natural Science Foundation, Key Project","award":["23JCZDJC00600"],"award-info":[{"award-number":["23JCZDJC00600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03438-9","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:51:06Z","timestamp":1792475466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["METTL14-mediated FDX1 m6A methylation inhibited the proliferation of clear cell renal cell carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Zhijie","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqun","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"3","key":"3438_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F. International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2015;67(3):519\u201330. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.002 . PubMed PMID: 25449206.","journal-title":"Eur Urol"},{"issue":"1","key":"3438_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"Cancer J Clin"},{"issue":"3","key":"3438_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","volume":"34","author":"K Gupta","year":"2008","unstructured":"Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev. 2008;34(3):193\u2013205. https:\/\/doi.org\/10.1016\/j.ctrv.2007.12.001 . PubMed PMID: 18313224.","journal-title":"Cancer Treat Rev"},{"key":"3438_CR4","doi-asserted-by":"publisher","unstructured":"Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urologic Clinics of North America. 2003; Follow-up Strategies and Management of Recurrence in Urologic Oncology 30(4):843\u201352. https:\/\/doi.org\/10.1016\/S0094-0143(03)00056-9","DOI":"10.1016\/S0094-0143(03)00056-9"},{"issue":"6","key":"3438_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0006-291X(62)90333-9","volume":"7","author":"LE Mortenson","year":"1962","unstructured":"Mortenson LE, Valentine RC, Carnahan JE. An electron transport factor from Clostridiumpasteurianum. Biochem Biophys Res Commun. 1962;7(6):448\u201352. https:\/\/doi.org\/10.1016\/0006-291X(62)90333-9.","journal-title":"Biochem Biophys Res Commun"},{"issue":"26","key":"3438_CR6","doi-asserted-by":"publisher","first-page":"11775","DOI":"10.1073\/pnas.1004250107","volume":"107","author":"AD Sheftel","year":"2010","unstructured":"Sheftel AD, Stehling O, Pierik AJ, Els\u00e4sser HP, M\u00fchlenhoff U, Webert H, et al. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe\/S cluster biosynthesis. Proc Natl Acad Sci U S A. 2010;107(26):11775\u201380. https:\/\/doi.org\/10.1073\/pnas.1004250107 . PubMed PMID: 20547883; PubMed Central PMCID: PMC2900682.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3438_CR7","doi-asserted-by":"publisher","first-page":"103930","DOI":"10.1016\/j.redox.2025.103930","volume":"88","author":"Y Lu","year":"2025","unstructured":"Lu Y, Wu Y, Yang C, Zhou Y, Ren X, Li H, et al. Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death. Redox Biol. 2025;88:103930. https:\/\/doi.org\/10.1016\/j.redox.2025.103930 . PubMed PMID: 41260099; PubMed Central PMCID: PMC12670532.","journal-title":"Redox Biol"},{"issue":"6586","key":"3438_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529 . PubMed PMID: 35298263; PubMed Central PMCID: PMC9273333.","journal-title":"Science"},{"key":"3438_CR9","doi-asserted-by":"publisher","unstructured":"Hr PTADKC, Z K. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15(7). https:\/\/doi.org\/10.1038\/s41589-019-0291-9 . PubMed PMID: 31133756.","DOI":"10.1038\/s41589-019-0291-9"},{"key":"3438_CR10","doi-asserted-by":"publisher","first-page":"112824","DOI":"10.1016\/j.intimp.2024.112824","volume":"140","author":"L Wei","year":"2024","unstructured":"Wei L, Liu S, Xie Z, Tang G, Lei X, Yang X. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression. Int Immunopharmacol. 2024;140:112824. https:\/\/doi.org\/10.1016\/j.intimp.2024.112824 . PubMed PMID: 39116490.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"3438_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/cancers15041033","volume":"15","author":"X Ji","year":"2023","unstructured":"Ji X, Wang Z, Sun W, Zhang H. The Emerging Role of m6A Modification in Endocrine Cancer. Cancers (Basel). 2023;15(4):1033. doi:10.3390\/cancers15041033 PubMed PMID: 36831377; PubMed Central PMCID: PMC9954123.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"3438_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.21037\/tau-23-682","volume":"13","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wang S, Yang X, Yang X, Zhou L. METTL14 inhibits the proliferation, migration and invasion of prostate cancer cells by increasing m6A methylation of CDK4. Transl Androl Urol. 2024;13(7):1145\u201363. https:\/\/doi.org\/10.21037\/tau-23-682 . PubMed PMID: 39100843; PubMed Central PMCID: PMC11291409.","journal-title":"Transl Androl Urol"},{"issue":"7","key":"3438_CR13","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.62347\/QHFA9669","volume":"14","author":"N Yu","year":"2024","unstructured":"Yu N, Wu Y, Wei Q, Li X, Li M, Wu W. m6A modification of CDC5L promotes lung adenocarcinoma progression through transcriptionally regulating WNT7B expression. Am J Cancer Res. 2024;14(7):3565\u201383. https:\/\/doi.org\/10.62347\/QHFA9669 . PubMed PMID: 39113868; PubMed Central PMCID: PMC11301290.","journal-title":"Am J Cancer Res"},{"key":"3438_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s40001-024-01968-4","volume":"29","author":"L Yang","year":"2024","unstructured":"Yang L, Liu J, Zhang J, Shao F, Jin Y, Xing J, et al. Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo. Eur J Med Res. 2024;29:405. https:\/\/doi.org\/10.1186\/s40001-024-01968-4 . PubMed PMID: 39103890; PubMed Central PMCID: PMC11299366.","journal-title":"Eur J Med Res"},{"issue":"7","key":"3438_CR15","doi-asserted-by":"publisher","first-page":"e1766","DOI":"10.1002\/ctm2","volume":"14","author":"L Li","year":"2024","unstructured":"Li L, Tang Q, Ge J, Wang D, Mo Y, Zhang Y, et al. METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m6A modification of ANKRD22 mRNA. Clin Transl Med. 2024;14(7):e1766. https:\/\/doi.org\/10.1002\/ctm2. 1766 PubMed PMID: 39021049; PubMed Central PMCID: PMC11255023.","journal-title":"Clin Transl Med"},{"issue":"1","key":"3438_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-022-01549-1","volume":"21","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lu Z, Qi C, Yu C, Li Y, Huan W, et al. N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Mol Cancer. 2022;21(1):111. https:\/\/doi.org\/10.1186\/s12943-022-01549-1 . PubMed PMID: 35538475; PubMed Central PMCID: PMC9087993.","journal-title":"Mol Cancer"},{"issue":"1","key":"3438_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-022-00831-5","volume":"20","author":"Z Liu","year":"2022","unstructured":"Liu Z, Sun T, Piao C, Zhang Z, Kong C. METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma. Cell Commun Signal. 2022;20(1):36. https:\/\/doi.org\/10.1186\/s12964-022-00831-5 . PubMed PMID: 35305660; PubMed Central PMCID: PMC8934459.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"3438_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrmicro2356","volume":"8","author":"B Py","year":"2010","unstructured":"Py B, Barras F. Building Fe\u2013S proteins: bacterial strategies. Nat Rev Microbiol. 2010;8(6):436\u201346. https:\/\/doi.org\/10.1038\/nrmicro2356.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"3438_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 . PubMed PMID: 35022204.","journal-title":"Cancer Discov"},{"issue":"1","key":"3438_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12885-021-07896-4","volume":"21","author":"F Zhao","year":"2021","unstructured":"Zhao F, Hao Z, Zhong Y, Xu Y, Guo M, Zhang B, et al. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation. BMC Cancer. 2021;21(1):194. https:\/\/doi.org\/10.1186\/s12885-021-07896-4.","journal-title":"BMC Cancer"},{"issue":"8","key":"3438_CR21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3109\/10715762.2012.671940","volume":"46","author":"SA Park","year":"2012","unstructured":"Park SA, Na HK, Surh YJ. Resveratrol suppresses 4-hydroxyestradiol-induced transformation of human breast epithelial cells by blocking I\u03baB kinase\u03b2-NF-\u03baB signalling. Free Radic Res. 2012;46(8):1051\u20137. https:\/\/doi.org\/10.3109\/10715762.2012.671940 . PubMed PMID: 22571807.","journal-title":"Free Radic Res"},{"key":"3438_CR22","doi-asserted-by":"publisher","first-page":"923737","DOI":"10.3389\/fgene.2022.923737","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zeng Y, Guo X, Shen H, Zhang J, Wang K, et al. Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker. Front Genet. 2022;13:923737. https:\/\/doi.org\/10.3389\/fgene.2022.923737.","journal-title":"Front Genet"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03438-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:51:06Z","timestamp":1792475466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03438-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3438"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03438-9","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No individual personal data (such as images or details) are included in this manuscript. Consent to Publish declaration: not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is not a clinical trial. Clinical trial number: not applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Second Hospital of Tianjin Medical University approved the study. All human tissue samples used in this study were obtained with informed consent from patients. All methods were performed in accordance with the relevant guidelines and regulations of the Ethics Committee of the Second Hospital of Tianjin Medical University.","order":4,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"341"}}